| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 579 | 29.304 | 84.280 | 169.169 | 183.246 | 208.797 | 122.280 | 185.799 | 183.873 |
| Total Income - EUR | - | 579 | 29.304 | 84.319 | 169.482 | 186.787 | 208.835 | 122.323 | 189.975 | 208.722 |
| Total Expenses - EUR | - | 112 | 7.195 | 62.161 | 103.369 | 98.322 | 112.433 | 85.114 | 127.735 | 151.540 |
| Gross Profit/Loss - EUR | - | 467 | 22.109 | 22.159 | 66.113 | 88.465 | 96.402 | 37.209 | 62.240 | 57.183 |
| Net Profit/Loss - EUR | - | 450 | 21.736 | 21.380 | 64.418 | 86.904 | 94.305 | 36.107 | 60.581 | 51.740 |
| Employees | - | 0 | 1 | 0 | 4 | 4 | 4 | 2 | 3 | 3 |
Check the financial reports for the company - Derma Visage Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 1.444 | 3.318 | 9.242 | 12.644 | 64.020 | 54.263 | 281.440 | 257.876 |
| Current Assets | - | 645 | 24.160 | 30.208 | 61.449 | 82.341 | 34.165 | 23.590 | 232.527 | 78.866 |
| Inventories | - | 0 | 0 | 15.593 | 15.115 | 16.913 | 6.818 | 11.542 | 23.294 | 10.363 |
| Receivables | - | 579 | 3.097 | 179 | 40.097 | 3.357 | 16.529 | 2.930 | 199.903 | 37.919 |
| Cash | - | 66 | 21.063 | 14.436 | 6.237 | 62.071 | 10.817 | 9.119 | 9.330 | 30.584 |
| Shareholders Funds | - | 494 | 22.222 | 21.432 | 64.468 | 86.954 | 94.353 | 65.822 | 96.627 | 51.789 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 151 | 3.381 | 12.094 | 6.222 | 8.032 | 3.849 | 12.067 | 221.602 | 115.587 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 195.738 | 169.796 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derma Visage Med Srl